Several domestic and imported probiotics brands in South Korea have been told to improve their product labelling following a report by the Korea Consumer Agency.
Australia’s Blackmores, Swisse, and GNC from the US were China’s most imported health foods brands across a range of top-selling product categories, according to a new report.
South Korean authorities are driving the globalisation of the country’s functional health foods by enhancing public-private partnership and supporting firms throughout the entire product lifecycle.
Major China probiotics firm Beijing Scitop Bio-Tech is to list publicly on the Shenzhen Stock Exchange, with the bulk of the investment received set to be channelled to the construction of a R&D centre.
Immune, digestive, cognitive health concerns have been listed as the key drivers in the development of new infant formula products – according to two industry experts.
Netherlands’ ingredients supplier Sensus is eyeing the digestive health market in Thailand with its chicory root products after securing a new health claim.
Singapore-based personalised nutrition firm Imagene Labs has forayed into the immune health space with a number of new launches, including a ginseng vitamin blend plus a DNA test which looks at one's genetic tendencies for nutritional deficiencies....
India’s BodyFirst Wellness Nutrition has partnered Bollywood star Suniel Shetty in addressing misconception around nutraceutical use and building consumer trust in the country.
India is well equipped to meet government ambitions to increase capabilities in manufacturing essential active pharmaceutical ingredient (APIs) – which also includes vitamins B1 and B6.
Australia-based Fiji Kava is selling its new sleep and relax range of kava supplements for the first time globally, with domestic supermarket chain Coles being the first to stock the products.
Regulators from China and importing countries should cooperate to arrest the problem of milk formula not intended for infant consumption being marketed as such in the China market, said an industry observer.
There is a lively debate among Indian experts around which Indian authority is best placed to help the nation’s nutra sector reach its growth, experts and innovation potential.
Grocery store sales have helped support the strong growth of natural health products sales in New Zealand, as footfall to pharmacies declined during the nation’s COVID-19 lockdown.
India’s nutraceutical ingredient suppliers have reported a higher demand for native ayurvedic herbs, such as turmeric and andrographis, especially from the US and Europe, partly due to COVID-19.
Japan’s Taisho Pharmaceutical Holdings is stepping up product development in its nutrition business, as its prescription pharmaceutical struggles to secure significant growth opportunities.
Singapore firm ONI Global, a franchisee of GNC, has reported ‘solid growth’ for its performance this year and made clear its intention to expand its brick-and-mortar presence – despite the financial woes being faced by the global retailer in the US.
BY-HEALTH is aiming to raise RMB$3.6bn (US$509m) to fund five new projects, including new manufacturing sites in China and Australia, and a health management centre.
India’s raw turmeric price this year is about 10% lower than last year partly because COVID-19 lockdowns and market closures have led to a surplus, said a major merchant association in India.
In this round-up, we zoom in on new developments in big brands, including how Amway India aims to achieve 90% of its pre-lockdown business by next month, Swisse adopting a ‘digital’ first strategy in India, and Ajinomoto’s debut in the VMS space.
Amway India’s CEO Anshu Budhraja says the firm is hopeful of achieving 80% to 90% of its pre-lockdown business by next month, as the country’s economy seeks to bounce back from COVID-19 pandemic.
Australian e-commerce platform BuyNatural believes there are “exceptional opportunities” in China for local dietary supplement brands, with consumers eager to purchase “newer and smaller” brands.
The New Zealand natural health products industry’s combined revenue last year was NZD$2.3bn (US$1.4bn), up 64% from five years ago, but the potential of even greater growth has been hampered by regulatory restrictions and low working capital.
South Korea’s authorities have recalled 12 krill oil products after safety tests found banned substances or excessive use of solvents in the products, leading to the authorities calling for tougher inspections at customs.
Chinese consumers see health benefits in probiotics, with probiotics in fermented dairy and beverages most popular, but misconceptions about the fast-rising ingredient are also rife, said a newly released consumers report.
A Singapore-based online customised supplement firm says the COVID-19 pandemic has helped consumers overcome scepticism to subscription services in the nutra space, after recording 60% year-on-year boost in sales over the last 30 days.
Australia’s complementary medicines sector continues to surge, with the sector officially valued at AUD$5.6bn last year (US$3.9bn), up from AUD$5.2bn (US$3.5bn) in 2018, while exports grew by another 15% to AUD$1.1bn (US$766m).
Nestle Health Science aims to launch nine new products from the Garden of Life series – a US health foods brand which it previously acquired – into the China market this year. Of which, immune, beauty, and anti-stress are the key product priorities.
More companies in APAC are seeking to increase the amount of micronutrient fortification in their food and beverages products on the back of COVID-19, says DSM.
CBD specialist Elixinol Global has managed to hit its capital raising target of AUD$11m (US$7.3m) following a two-stage fund raising exercise, which it believes is a proof of how its CBD supplements have resonated with its investors.
See May's 10 most read stories, including COVID-19's clinical trials research and what firms have done to cope with disruptions caused by the pandemic.
There are three weeks left to submit entries for the 2020 NutraIngredients-Asia Awards and stand a chance to be crowned among the region's brightest and best, and take your place on the roll of honour alongside our victorious companies from 2019.
Plant extract companies in China are seeing more demand for immune-related raw materials, but most are adopting a cautious stance when it comes to capacity building due to trade uncertainties brought on by COVID-19.
Australian supplements giant Blackmores is tapping investors for AUD117m (US$78m) to help drive its expansion in Asia – although the firm’s largest shareholder Marcus Blackmore won’t be among those dipping into his pocket.
This round-up looks at the latest China infant nutrition brand scandal, how probiotics can improve asthma control, and market developments from big brands, including BY-HEALTH and Nestle.
Both local Chinese and foreign infant nutrition brands in China are urged to “push hard on safety cues and messages” in light of the recent infant nutrition scandal happening in the country, according to an industry expert.
The standard of nutritional clinical research in APAC has improved by “leaps and bounds” in recent years, but researchers still need to take note of pitfalls such as biased judgements because strong science provides the cornerstone of commercially successful...
There are just four weeks left to submit entries for the 2020 NutraIngredients-Asia Awards and stand a chance to be crowned among the region's brightest and best.
Yakult has opened three new China sales offices, with the Japanese firm hopeful it will lead to an additional 100,000 bottle sales per day in a key market.
BY-HEALTH has refreshed its brand logo and product packaging in a bid to revitalise its vitamins and dietary supplements (VDS) business, at the same time as reporting disappointing revenue figures for the first quarter of the year.
Some of the latest consumers trends can be seen from the growing understanding of vitamins for preventive health in Indonesia, and the rising popularity of probiotics, infant nutrition, and Foods for Special Medical Purposes (FSMPs) in China as more spend...
China is stepping up its compliance checks on food manufacturers and retailers to stem the unauthorised production and sales of special foods, including Foods for Special Medical Purpose (FSMPs).
China’s infant formula and supplement retailer, GOVKING Group, is promoting GoldMax – a New Zealand infant formula and supplement brand – through its ‘livestreaming incubator’.
Industry leaders in Australia have hailed cross-party agreement that will lead to five years protection for clinical trials for complementary medicines and supplements, a world-first move that trade body Complementary Medicines Australia (CMA) says will...
Foods for Special Medical Purposes (FSMPs), probiotics and infant nutrition are among the fast-rising categories in China’s e-commerce space, according to two sector specialists featured in our latest Nutrition Asia video series.